NWBO

Northwest Biotherapeutics, Inc. NWBO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NWBO CVM AVXL ATNM RNXT IMUX IMUC CLDX ADXS
6M 2.87 % -13.89 % 4.63 % 14.62 % 43.78 % -0.19 % -35.71 % 58.97 % 223.90 %
YTD -9.08 % -34.89 % -23.70 % 18.25 % -18.38 % -11.91 % -46.75 % 3.80 % 268.89 %
1Y -12.78 % -73.31 % 71.35 % -15.34 % 11.00 % -38.46 % -23.08 % -11.59 % 268.89 %
3Y -62.37 % -91.74 % -15.50 % -80.65 % -32.73 % -91.68 % -88.00 % -16.47 % -94.73 %
5Y -75.30 % -98.24 % 107.85 % -85.89 % -84.71 % -95.34 % -80.85 % 56.09 % -99.69 %
10Y -95.69 % -98.50 % 3.92 % -97.76 % -84.71 % -99.56 % -80.85 % -85.95 % -100.00 %
From the beginning -99.98 % -99.69 % 15.88 % -96.69 % -84.71 % -99.81 % -80.85 % -96.95 % -100.00 %

Dividend

CEL-SCI Corporation